Atopic Dermatitis Drugs Market is Aesthetically Rising at a CAGR of 8.2% During Forecast to 2023
MRFR has published
research on “Atopic Dermatitis Drugs Market 2023”
Market Analysis :
The global atopic dermatitis
market is projected to grow substantially at a promising 8.2% CAGR over the
predicted years (2017-2023). Atopic dermatitis (AD) or eczema as it is
popularly known as is a chronic disease that is inflammatory and is
characterized by rashes and itchy skin lesions. Generally, every age group can
get affected by this skin disease but it is more common in case of children and
infants. Rising prevalence of skin irritants mainly cosmetics, perfumes,
detergents, soaps and water can produce inflammation. Eczema can be a result of
pharmacologic factors, genetic, immunological or complex interplay of the
environment. Every form of eczema causes redness and itching but atopic
dermatitis is the most severe. AD may misguide the immune system resulting in
chronic diseases later on. It has different patterns resting on the patients’
age. This can occur on the sides of the neck, inside the elbows, knees, ankles,
wrists and hands along with having a tendency of developing papules that
results in rashes.
There are many factors that
is driving the growth of the atopic dermatitis market.Some of these factors as
per the Market Research Future (MRFR) report include increasing prevalence of
atopic dermatitis, rising prevalence of food allergies, favorable reimbursement
policies, higher treatment compliance, higher unmet needs, promising pipeline
molecule, increasing access for treatment medication in developing countries, support
from the government for research and development,rising funding and advancing
technology. On the contrary, factors such as poor reimbursement policies and
side effects from drugs may hinder the growth of the Atopic Dermatitis Market.
Competitive Analysis:
The global Atopic
Dermatitis Market Size is fragmented and highly competitive and based
on clinical outcomes of products and new product launches. The key players are
using different strategies namely acquisitions, partnerships, joint ventures,
agreements, high expense on R&D, market initiatives, clinical trials and
new product launches to boost up their footprint in the atopic dermatitis
market.
Key Players:
Allergan Plc. (Republic of Ireland), Galderma S.A.
(Switzerland), Pfizer Inc. (U.S.), Meda Pharmaceuticals (U.S.), Bristol-Myers
Squibb (U.S.), Novartis International AG (Switzerland), Anacor Pharmaceuticals
Inc. (U.S.), Valeant Pharmaceuticals International, Inc (Canada), Regeneron
Pharmaceuticals, Inc. (U.S.), Sanofi S.A. (France), Astellas Pharma Inc.
(Japan)
Market Segmentation
·
Market
Research Future report offers an all-inclusive segmental analysis of the atopic dermatitis market on the basis of types,
application and end-user.
·
Based
on type, it is segmented into calcitonin, interferon, monoclonal antibodies,
erythropoietin, hormone and others.
·
Based
on application, the atopic dermatitis market is
segmented into infectious diseases, chronic diseases, blood disorders, cancer
and others.
·
Based on end-users, it is segmented into research centers,
clinics and hospitals.
Regional Analysis:
Based on region, the atopic dermatitis market covers growth opportunities and latest
trends across North America, Europe, Asia Pacific and Middle East and Africa. Of
these, North America will remain the luminary in the atopic dermatitis market. The factors that are driving the market
include high healthcare investment, government funding in research and
development, increasing use of skin irritants especially cosmetics and perfumes
and inflating patient pool. North America is followed by Europe that holds the
second largest share. Germany and France have increased their expenditure on
healthcare that ensures considerable market growth here. The atopic dermatitis
market in the Asia Pacific region is expected to grow at the fastest pace with
countries such as South Korea, China and India heavily investing in the
healthcare domain. South Korea and India are generating substantial demand. On
the other hand, the atopic dermatitis market in Middle East and Africa will
have a minimal share owing to ignorance, poor treatment facilities and lack of
disease screening.
Access Full Report Details and TOC Extensively @ https://www.marketresearchfuture.com/reports/atopic-dermatitis-market-1610
Comments
Post a Comment